Vistide
Replacement
|
Medicines
|
14/12/2011
The marketing authorization holder has informed its supplied customers by letter dated 14.12.2011 that the above mentioned batches have to be recalled due to a potential contamination with particles. This problem was identified during a GMP inspection of the manufacturer Ben Venue Laboratories (BVL) in Ohio/USA.
| Name of the medicinal product | Vistide 75 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/97/037/001 |
| Marketing authorisation holder | Gilead Sciences International Limited Durchführung Austausch: Gilead Sciences GesmbH |
| Batch number(s) | 1797701D, 1797701D1, 1797701D2, 1797701D3 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0310 |
Further inquiry note
Page last modified:
12/07/2022